A study to Compare the Pharmacokinetics of PF-06882961 in Adult Participants With Varying Degrees of Hepatic Impairment
A study to Compare the Pharmacokinetics of PF-06882961 in Adult Participants With Varying
Degrees of Hepatic Impairment. A Phase 1, Non-Randomized, Open-Label, Single- Dose, Parallel Cohort Study to Compare the Pharmacokinetics of PF-06882961 in Adult Participants With Varying Degrees of Hepatic Impairment Relative to Participants Without Hepatic
Impairment.
Category & Conditions: Diabetes and Metabolic Disorders
Medicine: danuglipron (PF-06882961)
ClinicalTrials.gov Identifier (NCT): NCT04604496
Protocol ID: C3421014
PrintDownloadOpen Plain Language Summary Result: Click here